… Given their effectiveness, the development of resistance to β-lactam antibiotics creates a …
This review focuses on the emergence of resistance to the 4 novel β-lactam–β-lactamase …

… First, the present study was conducted on a small number of clinical isolates of P. aeruginosa,
while in order to reach a definitive and complete result, the population of the population …

… A total of 100 clinical isolates of ESBL-producing K. pneumoniae collected throughout
Japan between June and July 2018 were studied. ESBL genes were analyzed using PCR and …

… In this paper, we describe the results of a 1-year molecular analysis of all ceftazidime-avibactam-resistant
clinical isolates collected from six hospitals in Rome. The strains studied, all …

… carbapenemase-producing clinical isolates which provides a presumptive diagnosis to inform
rapidly the selection of antibiotic therapy: an exceptional diagnostic and clinical strategy is …

… -encoded metallo-β-lactamase (VIM) and New Delhi metallo-β-lactamase (NDM). The first
acquired MBL (imipenemase; IMP-1), was reported from clinical isolates of P. aeruginosa and …

… Isolates possessing an altered PBP3 and bla NDM would be refractory to aztreonam/avibactam
and any clinically available β-lactams and β-lactam/BLI combinations. Recent studies …

… We conclude that MBL producing strains are widespread among the clinical isolates of P.
aeruginosa in Nepal and responsible for emerging MDR strains. It is paramount that antibiotics …

… coli clinical isolates with an ability to evade the onslaught of PBP3-targeting β-lactams
through … However, conceivably this was imminent, as β-lactams employed for Gram-negative …

… with any of the clinical isolates. No carbapenemase gene was detected for four isolates in
this study and … Two isolates were negative for all of β-lactamase gene detected in this study. …